Slides
Page 1
Samsung C&T 2Q 2026 Earnings Disclaimer: The figures in this document are consolidated earnings estimates based on K-IFRS. Please be advised that this document is provided solely for the purpose of investor convenience. It was prepared before the completion of external auditor's review, and therefore is subject to change during this process.
Page 2
CONTENTS 01 2Q 2026 Results (K-IFRS Consolidated) 03 Key Business Updates 02 Performance by Business Group 04 Appendix Samsung C&T 2Q 2026 Earnings Release
Page 3
2Q26 1Q26 2Q25 1H26 1H25 Change Change Change Sales 11,995 10,466 +1,529 10,022 +1,973 22,461 19,759 +2,702 E&C 3,988 3,413 +575 3,395 +593 7,401 7,015 +386 T&I 4,703 4,114 +589 3,776 +927 8,817 7,212 +1,605 Fashion 593 573 +20 510 +83 1,166 1,014 +152 Leisure 206 105 +101 223 (17) 311 331 (20) F&B* 886 825 +61 828 +58 1,711 1,599 +112 Bio** 1,619 1,436 +183 1,290 +329 3,055 2,588 +467 Gross Profit 2,214 1,869 +345 1,801 +413 4,083 3,554 +529 SG&A 1,182 1,149 +33 1,048 +134 2,331 2,077 +254 Operating Profit OP Margin 1,032 720 +312 753 +279 1,752 1,477 +275 8.6% 6.9% +1.7%p 7.5% +1.1%p 7.8% 7.5% +0.3%p E&C 202 111 +91 118 +84 313 277 +36 T&I 142 109 +33 80 +62 251 143 +108 Fashion 54 38 +16 33 +21 92 67 +25 Leisure 0 (35) +35 9 (9) (35) (22) (13) F&B* 48 14 +34 45 +3 62 64 (2) Bio** 586 483 +103 468 +118 1,069 948 +121 Non-Operating Profit (11) 526 (537) (8) (3) 515 428 +87 Financial Profit 34 58 (24) (9) +43 92 6 +86 Equity Method Investment 22 41 (19) 17 +5 63 46 +17 Profit Before Income Tax 1,077 1,345 (268) 753 +324 2,422 1,957 +465 Net Profit 916 1,086 (170) 527 +389 2,002 1,464 +538 └ Controlling 596 844 (248) 353 +243 1,440 1,085 +355 2Q 2026 Results (K-IFRS Consolidated) (KRW bn) 3 * F&B (Welstory): 100% subsidiary, ** Bio (Biologics: 43.06% subsidiary, Epis Holdings: 43.06% subsidiary)
Page 4
1.1 1.3 3.4 5.5 13.0 2022 2023 2024 2025 2026 Target/Actual Engineering & Construction Performance by Business Group 2Q 2026 Profit & Loss (KRW bn) • Sales and OP increased QoQ, driven by the ramp-up of High-Tech P4 finishing works and P5 structural frame construction, as well as robust progress across overseas plant projects secured last year 4 (KRW bn)2Q 2026 New Orders Major New Orders • 2Q26 New Orders (KRW 5.4 tn) - Anyang Stadium Redevelopment (0.8tn), Daechi Ssangyong 1st (0.7tn), China Xi'an FAB (0.5tn), National AI Computing Center (0.5tn), Malaysia Data Center (0.3tn), Giheung NRD-K2 (0.3tn), Pyeongtaek P5 FAB2 (0.3tn), etc. • 2Q26 Housing Construction Rights Secured (KRW 4.0 tn) < Annual Housing Construction Rights Secured > * Total & Domestic figures include Leisure GSS (Green Space Solution, landscape) (2Q: KRW 48.2bn, 1H: KRW 71.7bn, Backlog: KRW 174.4bn) • Sales and OP growth is expected to continue in 3Q as High-Tech project construction gains momentum; on a full-year basis, we anticipate the momentum to accelerate in 2H • Increasehigh-quality orders by capturing growing globalenergy demand and leveragingthe competitiveness of our residential brand, aiming to achieve our 2026 order and sales guidance 2Q Earnings Outlook - Apgujeong District 4 (2.1tn), Gaepo Woosung 4th (0.8tn), Bangbae Shinsamho (0.7tn), Shinbanpo 19th&25th (0.4tn) 4.0 (KRW tn) 2Q26 1Q26 2Q25 Change Change Sales 3,988 3,413 +575 3,395 +593 Building 2,631 2,245 +386 2,329 +302 Civil 127 108 +19 159 (32) Plant 1,230 1,060 +170 907 +323 Domestic 2,122 1,395 +727 1,586 +536 Overseas 1,866 2,018 (152) 1,809 +57 Gross Profit 459 399 +60 366 +93 Operating Profit 202 111 +91 118 +84 OP Margin 5.1% 3.2% +1.9%p 3.5% +1.6%p 2Q New Orders 1H New Orders Backlog Total 5,448 10,448 34,244 Building 5,044 9,952 23,813 Civil 38 43 1,183 Plant 366 453 9,248 Domestic 3,515 8,178 19,890 Overseas 1,933 2,270 14,354
Page 5
21 48 58 77 79 32 10 14 15 25 20 16 2021 2022 2023 2024 2025 1H26 Trading & Investment Performance by Business Group (KRW bn) 2Q 2026 Profit & Loss Price Trend of Key Commodities Solar PV Development Business Results Gains from the sales of development assets (USD mn) Pipeline capacity (GW) (USD/MT) 5 2Q26 1Q26 2Q25 Change Change Urea 668 532 +25.6% 391 +70.8% Hot-rolled Steel 561 540 +3.9% 532 +5.5% Cold-rolled Steel 638 577 +10.6% 614 +3.9% Nickel 18,165 17,364 +4.6% 15,178 +19.7% Copper 13,326 12,848 +3.7% 9,519 +40.0% 2Q Earnings Outlook • Earnings improved QoQ, driven by timely action in response to rising chemical and fertilizer prices, increased sales of high-margin steel products, and a rise in nickel prices • Earnings are expected to moderate QoQ in 3Q due to lower volumes from a downturn in market conditions and the adoption of EU's steel import quotas; on a full-year basis, we anticipate diversifying chemicals, fertilizer, and non-ferrous metals markets and expanding sales of high-margin steel products • 2Q26 disposal gains: USD 22.2mn in 1Q (Australia: 7.5mn), USD 9.5mn in 2Q • 2026 outlook: pipeline of approximately 20GW * Retaining capacity at the end of each term (Cumulative development – Cumulative sale), including the US/Australia/ESS 2Q26 1Q26 2Q25 Change Change Sales 4,703 4,114 +589 3,776 +927 Industrial Materials 4,461 3,891 +570 3,558 +903 Energy 16 40 (24) 20 (4) Tech 226 183 +43 198 +28 Gross Profit 380 313 +67 249 +131 Operating Profit 142 109 +33 80 +62 OP Margin 3.0% 2.7% +0.3%p 2.1% +0.9%p
Page 6
6 Fashion Performance by Business Group Leisure Performance by Business Group (KRW bn) 2Q 2026 Profit & Loss (KRW bn) 2Q 2026 Profit & Loss 2Q Earnings Outlook 2Q Earnings Outlook • Earnings declined YoY due to a decrease in park visitors amid dispersed leisure demand, as well as the completion of a large-scale Landscape (GSS) project • While leisure demand is expected to remain dispersed in 3Q, we will strengthen Caribbean Bay's competitiveness and capture peak-season demand through seasonal content; on a full-year basis, we will remain committed to increasing customer traffic • Amid improving consumer sentiment, sales growth continued for our core and newly launched brands, while profitability improved YoY through stronger discount management • YoY growth is expected to soften in 3Q due to weaker consumer sentiment; on a full-year basis, we will pursue earnings improvement by further strengthening the competitiveness of products and brands 2Q26 1Q26 2Q25 Change Change Sales 593 573 +20 510 +83 Operating Profit 54 38 +16 33 +21 OP Margin 9.1% 6.6% +2.5%p 6.5% +2.6%p 2Q26 1Q26 2Q25 Change Change Sales 206 105 +101 223 (17) Operating Profit 0 (35) +35 9 (9) OP Margin 0.0% (33.3%) +33.3%p 4.0% (4.0%p)
Page 7
7 Bio * Samsung Biologics: 43.06% subsidiary Samsung Epis Holdings: 43.06% subsidiary * Bioepis portion of Biologics' earnings prior to the spin-off (reflecting consolidation adjustments) 2Q Earnings Outlook F&B 2Q Earnings Outlook (KRW bn) 2Q 2026 Profit & Loss (KRW bn) 2Q 2026 Profit & Loss • Earnings increased YoY, driven by increased meal volumes attributable to newly secured food service operations and growth in the food distribution business • Earnings are anticipated to improve YoY in 3Q through new orders focusing on profitability and enhanced operational efficiency; on a full-year basis, solid growth is expected to continue • (Biologics) YoY growth was driven by full-capacity operation of Plants 1–4 and favorable foreign exchange effects • (Epis Holdings) Earnings declined YoY mainly due to changes in the timing of product supply • (Biologics) Annual sales growth (+15–20% YoY) is expected to continue through the gradual ramp-up of Plant 5 and the Rockville Campus in the U.S., with profitability projected to remain at the prior-year level • (Epis Holdings) Annual sales are expected to grow more than +10% YoY on expanded biosimilar sales, with profitability projected to remain at the prior- year level due to development costs for follow-on biosimilars and new drugs * Welstory: Wholly owned subsidiary 2Q26 1Q26 2Q25 Change Change Sales 1,619 1,436 +183 1,290 +329 Biologics 1,226 982 +244 889 +337 Epis Holdings* 393 454 (61) 401 (8) Operating Profit OP Margin 586 36.2% 483 33.7% +103 +2.5%p 468 36.3% +118 (0.1%p) Biologics OP Margin 580 47.3% 421 42.9% +159 4.4%p 445 50.0% +135 (2.7%p) Epis Holdings* OP Margin 6 1.4% 62 13.8% (56) (12.4%p) 23 5.7% (17) (4.3%p) 2Q26 1Q26 2Q25 Change Change Sales 886 825 +61 828 +58 Operating Profit 48 14 +34 45 +3 OP Margin 5.4% 1.7% +3.7%p 5.4% -
Page 8
Key Business Updates 8 - (Power/LNG) Continue to participate in projects in existing markets, while expanding into new markets, including Southeast Asia and Europe - (PV/BESS) Expand into southwestern Korea, Australia, North America, etc., by securing development and operational capabilities through a range of BMs, including large-scale EPC execution and partnership-based equity investments Aim to develop new business opportunities in energy, data centers, etc. in response to market changes, including growth in global AI investment ❖ Energy Solutions: diversify markets to address rising energy demand across countries and expand business opportunities through early involvement - (SMR) Aim for projects totaling 12.2GW, centered on five European countries · With GVH: projects in Sweden, Poland, Estonia, Finland, etc. (11.7GW in total) · With NuScale: planning participation in Romania's first-of-a-kind unit (0.5GW) - (Large-scale NPP) Address market expansion by simultaneously adopting multiple technology models under the Team Korea initiative · Vietnamese NPP Unit 2: Team Korea's construction contractor to be selected in 2027 (Targeting construction agreement in early-2027, groundbreaking in 2027, and commercial operation in 2035) · Romanian Units 3&4: pursue participation as contractor in collaboration with KHNP (4Q26) (Targeting FID&EPC contracts in 2027, groundbreaking in 2029, and commercial operation in 2035) ❖ Data Centers: Strengthen competitiveness by diversifying business models, including offering various solutions - Pursue follow-on orders linked to global Cloud Service Providers - Promote additional orders in Korea and Southeast Asia (Malaysia, Thailand, etc.) ※ Targeting over KRW 2tn for 2026 orders — including the Malaysia Data Center(0.3tn), Yongin Deokseong IDC (0.5tn), and the National AI Computing Center (0.5tn) * Modular DC, integrated DC+power generation, etc. Remain committed to identifying new business opportunities through the Life Science CVC Funds Energy / Data Center Bio / Life Science ❖ Biologics to acquire Swiss PolyPeptide (approx. KRW 2.7 tn) - Expanding the CDMO business portfolio by securing new technological capabilities in the peptide sector, which has been growing rapidly centering on obesity and diabetes treatments - Securing manufacturing facilities and bases in Europe, following the US * APR1400, AP1000, CANDU ❖ Aim to establish Life Science Fund III (KRW 200 bn / SCT's contribution: KRW 79.2bn) - Cumulative funds totaling KRW 442 bn (SCT: KRW 228.1bn) including Fund I of KRW 170 bn (SCT: KRW 99 bn) and Fund II of KRW 72 bn (SCT: KRW 49.9 bn) - Expanding strategic partnership opportunities by identifying global companies with next-generation innovative technologies in bio/life science and executing proactive investments ※ In May 2026, invested in Cartography Biosciences, a US-based company with an antigen target and drug discovery platform based on genomic data and AI technology (Fund I)
Page 9
Appendix Statement of Financial Position (K-IFRS Consolidated) Category 2Q26 1Q26 End of 2025Change Change Asset 163,769 105,087 +58,682 86,533 +77,236 Current 24,007 23,121 +886 21,356 +2,651 └ C&CE*(a) 7,770 6,695 +1,075 5,527 +2,243 Non-current 139,762 81,966 +57,796 65,177 +74,585 Liabilities 50,060 34,971 +15,089 29,036 +21,024 Current 16,003 15,341 +662 13,872 +2,131 Non-current 34,057 19,630 +14,427 15,164 +18,893 ※ Total debt** (b) 3,087 3,981 (894) 3,392 (305) Equity 113,709 70,116 +43,593 57,497 +56,212 Controlling 105,553 62,286 +43,267 49,912 +55,641 Non-controlling 8,156 7,830 +326 7,585 +571 Debt/Equity 44% 50% (6%) 51% (6%) Current ratio 150% 151% (1%) 154% (4%) Total Debt-to-Total Asset ratio 1.9% 3.8% (1.9%) 3.9% (2.0%) Net cash (a-b) 4,683 2,714 +1,969 2,135 +2,548 * C&CE: Cash and cash equivalents + short-term financial instruments, etc. ** Total Debt: Short-term borrowings + Current portion of long-term borrowings + Non-current long-term borrowings, etc. (KRW bn) 9
Page 10
Appendix Statement of Cash Flow (K-IFRS Consolidated) Category 2Q26 1Q26 1H26 End of 2025 Cash (Beginning of Period) 4,636 3,458 3,458 3,622 Cash flows from operating activities +2,506 +1,147 +3,653 +3,034 Net Profit +916 +1,086 +2,002 +3,906 Changes in operating assets and liabilities +776 +111 +887 (1,658) Others +814 (50) +764 +786 Cash flows from investing activities (966) (587) (1,553) (1,845) Changes in tangible/intangible assets (229) (191) (420) (1,770) Changes in equities (124) (545) (669) +136 Others (613) +149 (464) (211) Cash flows from financing activities (1,320) +618 (702) (1,353) Changes in borrowings (899) +558 (341) (486) Others (421) +60 (361) (867) Increase in cash +220 +1,178 +1,398 (164) Cash (End of Period) 4,856 4,636 4,856 3,458 (KRW bn) 10
Page 11
THE END